The publication preferred product characteristics (PPC) for therapeutic TB vaccines provides guidance to scientists, funding agencies, public and private sector organizations developing such [...]
IGTP (Germans Trias o Pujol Research Institute) has a vacancy. Please read the vacancy text
TBVI is pleased to announce the TBVI meeting “Accelerating the TB vaccine pipeline – towards Horizon Europe” in Les Diablerets. The meeting will be held from 27th to 29th of January [...]
The Tuberculosis Vaccine Initiative (TBVI) and IAVI have recently updated and expanded the TB Vaccine Development Pathway, a methodology and tool that provides a structured development path and [...]
The workshop “Maintaining European scientific excellence and global leadership in TB Vaccine R&D EU funded collaborative research and innovation” organised by three H2020 funded projects [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
